Laddar...
Evaluation of Dosing Practices of Rivaroxaban and Dabigatran
Background: Anticoagulation is standard practice for the prevention and treatment of thromboembolic events. Two of the newer agents, rivaroxaban (Xarelto) and dabigatran (Pradaxa) are being utilized frequently in the inpatient and outpatient settings. Prescribers may not appreciate the need for dose...
Sparad:
| I publikationen: | J Pharm Technol |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
SAGE Publications
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5990184/ https://ncbi.nlm.nih.gov/pubmed/34860911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/8755122514567923 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|